Bonaventura Clotet, M.D., Ph.D.
Dr. Clotet, who provided coverage of the 4th European HIV Drug Resistance Workshop, is chief of the Internal Medicine HIV Unit at the University Hospital Germans Trias i Pujol in Barcelona, Spain. Since 1994, he has also served as the director of the Retrovirology Laboratory at the "irsiCaixa Foundation," a leading institute for the research and treatment of HIV in Europe.
A prolific writer, Dr. Clotet has authored and co-authored more than 200 articles, which have appeared in international peer-reviewed scientific publications focused on infectious diseases and HIV, and more than 20 medical books. Since 1998 he has also been a reviewer of submitted papers for the following journals: AIDS, AIDS Research and Human Retroviruses, The Journal of Infectious Diseases, Clinical Infectious Diseases and The Lancet. He currently serves on the editorial board of the Journal of the International Association of Physicians in AIDS Care, AIDS and Current HIV/AIDS Reports.
Apart from his clinical work at the University Hospital Germans Trias i Pujol, Dr. Clotet is involved in many professional societies, such as EuroSIDA, the European AIDS Clinical Society, and the International AIDS Society-USA. He is part of the organizing committees for several drug resistance workshops and the International AIDS Conference, and he is an active member of the expert commission for the evaluation of research projects in the National Programme of Health and National AIDS Programme.
Dr. Clotet received his medical degree in 1976 from the Universitat Autònoma de Barcelona and completed his post-graduate training in internal medicine and infectious diseases at the Vall d'Hebron University Hospital. He went on to earn his Ph.D. in the investigation of surrogate markers for connective tissue diseases.
Dr. Clotet has received research funding from the following concerns: BECA FISss, Commission of the European Communities Biomedical and Health Research (BIOMED II), FISss, Fundacion Glaxo Wellcome, Fundacion para la investigacion y la prevencion del SIDA en Espana, Maraton de TV3, Ministeri d'Educacio i Cultura, Ministerio de Sanidad y Consumo, Plan Nacional de I+D and Proyectos I+D. He has also served as a consultant for Abbott Laboratories, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline and Roche Labs.